Upregulation of lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human endothelial cells by modified high density lipoproteins

Biochemical and Biophysical Research Communications

Volumn 428, Issue 2, 2012, Pages 230-233

  Pirillo, Angela ^a,b   Uboldi, Patrizia ^c   Ferri, Nicola ^c   Corsini, Alberto ^c   Kuhn, Hartmut ^d   Catapano, Alberico Luigi ^b,c  

^a Bassini Hospital   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

15 Lipoxygenase; Endothelial cells; High density lipoprotein; LOX 1

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; HIGH DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ARACHIDONATE 15-LIPOXYGENASE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, HDL3; SCAVENGER RECEPTORS, CLASS E; UP-REGULATION;

EID: 84869239068     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.020     Document Type: Article

References (32)

1. Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y., Tanaka T., Miwa S., Katsura Y., Kita T., Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997, 386:73-77.
2. Itabe H. Oxidative modification of LDL: its pathological role in atherosclerosis. Clin. Rev. Allergy Immunol. 2009, 37:4-11.
3. Sattler W., Malle E., Kostner G.M. Methodological approaches for assessing lipid and protein oxidation and modification in plasma and isolated lipoproteins. Methods Mol. Biol. 1998, 110:167-191.
4. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115:1285-1295.
5. Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler. Thromb. Vasc. Biol. 2007, 27:266-274.
6. Dunn S., Vohra R.S., Murphy J.E., Homer-Vanniasinkam S., Walker J.H., Ponnambalam S. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem. J. 2008, 409:349-355.
7. Mitra S., Goyal T., Mehta J.L. Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc. Drugs Ther. 2011, 25:419-429.
8. Mehta J.L., Chen J., Hermonat P.L., Romeo F., Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc. Res. 2006, 69:36-45.
9. Vohra R.S., Murphy J.E., Walker J.H., Ponnambalam S., Homer-Vanniasinkam S. Atherosclerosis and the lectin-like oxidized low-density lipoprotein scavenger receptor. Trends Cardiovasc. Med. 2006, 16:60-64.
10. Hofnagel O., Luechtenborg B., Stolle K., Lorkowski S., Eschert H., Plenz G., Robenek H. Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1789-1795.
11. Mehta J.L., Sanada N., Hu C.P., Chen J., Dandapat A., Sugawara F., Satoh H., Inoue K., Kawase Y., Jishage K., Suzuki H., Takeya M., Schnackenberg L., Beger R., Hermonat P.L., Thomas M., Sawamura T. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ. Res. 2007, 100:1634-1642.
12. Inoue K., Arai Y., Kurihara H., Kita T., Sawamura T. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circ. Res. 2005, 97:176-184.
13. Ishino S., Mukai T., Kume N., Asano D., Ogawa M., Kuge Y., Minami M., Kita T., Shiomi M., Saji H. Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability-analysis in hypercholesterolemic rabbits. Atherosclerosis 2007, 195:48-56.
14. Kuge Y., Kume N., Ishino S., Takai N., Ogawa Y., Mukai T., Minami M., Shiomi M., Saji H. Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits. Biol. Pharm. Bull. 2008, 31:1475-1482.
15. Li D.Y., Chen H.J., Staples E.D., Ozaki K., Annex B., Singh B.K., Vermani R., Mehta J.L. Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesions. J. Cardiovasc. Pharmacol. Ther. 2002, 7:147-153.
16. Besler C., Luscher T.F., Landmesser U. Molecular mechanisms of vascular effects of high-density lipoprotein: alterations in cardiovascular disease. EMBO Mol. Med. 2012, 4:251-268.
17. Mineo C., Deguchi H., Griffin J.H., Shaul P.W. Endothelial and antithrombotic actions of HDL. Circ. Res. 2006, 98:1352-1364.
18. Seetharam D., Mineo C., Gormley A.K., Gibson L.L., Vongpatanasin W., Chambliss K.L., Hahner L.D., Cummings M.L., Kitchens R.L., Marcel Y.L., Rader D.J., Shaul P.W. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ. Res. 2006, 98:63-72.
19. Ragbir S., Farmer J.A. Dysfunctional high-density lipoprotein and atherosclerosis. Curr. Atheroscler. Rep. 2010, 12:343-348.
20. Norata G.D., Pirillo A., Catapano A.L. Modified HDL: biological and physiopathological consequences. Nutr. Metab. Cardiovasc. Dis. 2006, 16:371-386.
21. Folcik V.A., Nivar-Aristy R.A., Krajewski L.P., Cathcart M.K. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 1995, 96:504-510.
22. Kuhn H., Heydeck D., Hugou I., Gniwotta C. In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J. Clin. Invest. 1997, 99:888-893.
23. Pirillo A., Uboldi P., Kuhn H., Catapano A.L. 15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages. Biochim. Biophys. Acta 2006, 1761:292-300.
24. Pirillo A., Uboldi P., Bolego C., Kuhn H., Catapano A.L. The 15-lipoxygenase-modified high density lipoproteins 3 fail to inhibit the TNF-alpha-induced inflammatory response in human endothelial cells. J. Immunol. 2008, 181:2821-2830.
25. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52:2745-2756.
26. Pirillo A., Reduzzi A., Ferri N., Kuhn H., Corsini A., Catapano A.L. Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells. Atherosclerosis 2011, 214:331-337.
27. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34:1345-1353.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
29. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 1993, 91:2546-2551.
30. Norata G.D., Tibolla G., Seccomandi P.M., Poletti A., Catapano A.L. Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells. J. Clin. Endocrinol. Metab. 2006, 91:546-554.
31. Kume N., Murase T., Moriwaki H., Aoyama T., Sawamura T., Masaki T., Kita T. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ. Res. 1998, 83:322-327.
32. Marsche G., Levak-Frank S., Quehenberger O., Heller R., Sattler W., Malle E. Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-modified high density lipoprotein on human umbilical venous endothelial cells. FASEB J. 2001, 15:1095-1097.